David R. Gagnon, MD, PhD

Associate Professor, Biostatistics
David Gagnon
(617) 638-5172gagnon@bu.edu
Crosstown Center – CT328
View full profile at BUMC


David Gagnon, MD MPH PhD is Associate Professor of Biostatistics. Dr. Gagnon is a biostatistician for the Framingham Foot Study and a senior biostatistician for the Massachusetts Veterans Epidemiology Research and Information Center [MAVERIC] located at the Boston VA hospital. He currently teaches Categorical Data Analysis [BS821], Advanced Methods in Statistical Computing [BS822] and Applications of Statistical Methods in Clinical Research [BS775]. Dr Gagnon’s research interests are in the areas of pharmacoepidemiology, longitudinal data analysis, survival analysis and statistical computing.


  • Saint Anselm College, BA
  • Tufts University, MD
  • Boston University, MPH
  • Boston University School of Public Health, PhD

Classes Taught

  • SPHBS775
  • SPHBS821


  • Published on 3/1/2014

    Moy ML, Teylan M, Weston NA, Gagnon DR, Danilack VA, Garshick E. Daily Step Count Is Associated With Plasma C-Reactive Protein and IL-6 in a US Cohort With COPD. Chest. 2014 Mar 1; 145(3):542-50.

    Read at: PubMed
  • Published on 2/20/2014

    Hermos JA, Quach L, Gagnon DR, Weber HC, Altincatal A, Cho K, Lawler EV, Grotzinger KM. Incident severe thrombocytopenia in veterans treated with pegylated interferon plus ribavirin for chronic hepatitis C infection. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):480-8.

    Read at: PubMed
  • Published on 2/19/2014

    Cho K, Gagnon DR, Driver JA, Altincatal A, Kosik N, Lanes S, Lawler EV. Dementia Coding, Workup, and Treatment in the VA New England Healthcare System. Int J Alzheimers Dis. 2014; 2014:821894.

    Read at: PubMed
  • Published on 2/1/2014

    Moy ML, Teylan M, Danilack VA, Gagnon DR, Garshick E. An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014 Feb; 11(2):149-57.

    Read at: PubMed
  • Published on 1/1/2014

    Doherty AL, Battaglino RA, Donovan J, Gagnon D, Lazzari AA, Garshick E, Zafonte R, Morse LR. Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury. J Bone Miner Res. 2014 Jan; 29(1):251-9.

    Read at: PubMed
  • Published on 12/1/2013

    Maron BA, Goldstein RH, Rounds SI, Shapiro S, Jankowich M, Garshick E, Moy ML, Gagnon D, Choudhary G. Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension associated with chronic obstructive Lung Disease) trial. Pulm Circ. 2013 Dec; 3(4):889-97.

    Read at: PubMed
  • Published on 9/6/2013

    Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy-Antiepileptic drug and osteoporosis prevention trial. Epilepsia. 2013 Nov; 54(11):1997-2004.

    Read at: PubMed
  • Published on 4/4/2013

    Moy ML, Teylan M, Weston NA, Gagnon DR, Garshick E. Daily step count predicts acute exacerbations in a US cohort with COPD. PLoS One. 2013; 8(4):e60400.

    Read at: PubMed
  • Published on 2/15/2013

    Reichmann WM, LaValley MP, Gagnon DR, Losina E. Impact of misspecifying the distribution of a prognostic factor on power and sample size for testing treatment interactions in clinical trials. BMC Med Res Methodol. 2013; 13:21.

    Read at: PubMed
  • Published on 1/1/2013

    Nguyen US, Dufour AB, Positano RG, Dines JS, Dodson CC, Gagnon DG, Hillstrom HJ, Hannan MT. The occurrence of ipsilateral or contralateral foot disorders and hand dominance: the framingham foot study. J Am Podiatr Med Assoc. 2013 Jan-Feb; 103(1):16-23.

    Read at: PubMed

View 78 more publications:View full profile at BUMC